Invesco’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
93,684
+3,540
+4% +$96.5K ﹤0.01% 2382
2025
Q4
$2.45M Buy
90,144
+11,258
+14% +$297K ﹤0.01% 2535
2025
Q3
$2.04M Buy
78,886
+16,000
+25% +$371K ﹤0.01% 2604
2025
Q2
$1.28M Buy
62,886
+10,443
+20% +$203K ﹤0.01% 2748
2025
Q1
$952K Buy
52,443
+10,342
+25% +$231K ﹤0.01% 2853
2024
Q4
$1.06M Buy
42,101
+871
+2% +$23.7K ﹤0.01% 2901
2024
Q3
$1.4M Buy
41,230
+97
+0.2% +$3.7K ﹤0.01% 2771
2024
Q2
$1.52M Sell
41,133
-173,215
-81% -$6.54M ﹤0.01% 2726
2024
Q1
$9M Sell
214,348
-43,215
-17% -$1.77M ﹤0.01% 1881
2023
Q4
$10.2M Buy
257,563
+220,428
+594% +$6.48M ﹤0.01% 1804
2023
Q3
$1.02M Buy
37,135
+8,225
+28% +$258K ﹤0.01% 2853
2023
Q2
$981K Sell
28,910
-66,246
-70% -$2.23M ﹤0.01% 2909
2023
Q1
$3.42M Buy
95,156
+18,674
+24% +$806K ﹤0.01% 2404
2022
Q4
$3.41M Buy
76,482
+59,505
+351% +$2.12M ﹤0.01% 2427
2022
Q3
$477K Sell
16,977
-2,997
-15% -$91.9K ﹤0.01% 3267
2022
Q2
$539K Buy
19,974
+1,851
+10% +$53.8K ﹤0.01% 3290
2022
Q1
$616K Sell
18,123
-189,549
-91% -$6.06M ﹤0.01% 3292
2021
Q4
$8.03M Sell
207,672
-326,313
-61% -$14.2M ﹤0.01% 2141
2021
Q3
$28.8M Buy
533,985
+103,578
+24% +$4.86M 0.01% 1327
2021
Q2
$14.4M Buy
430,407
+169,912
+65% +$4.66M ﹤0.01% 1825
2021
Q1
$5.37M Buy
+260,495
New +$5.98M ﹤0.01% 2345
2020
Q4
Sell
-534,584
Closed -$7.93M 3781
2020
Q3
$7.93M Buy
+534,584
New +$6.26M ﹤0.01% 1770
2020
Q1
Sell
-39,394
Closed -$88K 3650
2019
Q4
$88K Sell
39,394
-2,603
-6% -$6.04K ﹤0.01% 3613
2019
Q3
$89K Sell
41,997
-1,644
-4% -$3.81K ﹤0.01% 3635
2019
Q2
$117K Sell
43,641
-1,507
-3% -$5.12K ﹤0.01% 3672
2019
Q1
$222K Buy
45,148
+33,603
+291% +$177K ﹤0.01% 3597
2018
Q4
$34K Buy
11,545
+1,217
+12% +$5.98K ﹤0.01% 3728
2018
Q3
$70K Buy
10,328
+1,961
+23% +$13.7K ﹤0.01% 3805
2018
Q2
$63K Sell
8,367
-6,248
-43% -$83.5K ﹤0.01% 3796
2018
Q1
$511K Buy
14,615
+2,965
+25% +$115K ﹤0.01% 3321
2017
Q4
$496K Sell
11,650
-8
-0.1% -$343 ﹤0.01% 3309
2017
Q3
$500K Buy
11,658
+217
+2% +$8.13K ﹤0.01% 3305
2017
Q2
$424K Buy
11,441
+6,570
+135% +$291K ﹤0.01% 3373
2017
Q1
$264K Buy
4,871
+3,034
+165% +$158K ﹤0.01% 3538
2016
Q4
$98K Buy
1,837
+10
+0.5% +$569 ﹤0.01% 3607
2016
Q3
$111K Sell
1,827
-2,025
-53% -$126K ﹤0.01% 3588
2016
Q2
$253K Sell
3,852
-402
-9% -$25.5K ﹤0.01% 3475
2016
Q1
$242K Sell
4,254
-41,954
-91% -$4.72M ﹤0.01% 3506
2015
Q4
$10.9M Buy
46,208
+5,426
+13% +$1.18M ﹤0.01% 1443
2015
Q3
$6.45M Buy
40,782
+1,968
+5% +$557K ﹤0.01% 1691
2015
Q2
$14.7M Sell
38,814
-11,966
-24% -$4.75M 0.01% 1357
2015
Q1
$21.2M Buy
50,780
+13,735
+37% +$4.91M 0.01% 1170
2014
Q4
$10.1M Hold
37,045
﹤0.01% 1526
2014
Q3
$7.2M Sell
37,045
-6,658
-15% -$1.45M ﹤0.01% 1699
2014
Q2
$10.7M Sell
43,703
-348
-0.8% -$78.6K ﹤0.01% 1519
2014
Q1
$11.7M Sell
44,051
-3,295
-7% -$1.26M ﹤0.01% 1450
2013
Q4
$17.2M Buy
47,346
+15,486
+49% +$5.97M 0.01% 1256
2013
Q3
$16.9M Buy
31,860
+28,863
+963% +$9.9M 0.01% 1216
2013
Q2
$702K Buy
+2,997
New +$590K ﹤0.01% 3111

Other funds holding CLDX